Abstract
The emergence of compensatory mutations in the polymerase gene of drug resistant hepatitis B virus (HBV) is associated with treatment failure. We previously identified a multi-drug resistant HBV mutant, which displayed resistance towards lamivudine (LMV), clevudine (CLV), and entecavir (ETV), along with a strong replication capacity. The aim of this study was to identify the previously unknown compensatory mutations, and to determine the clinical relevance of this mutation during antiviral therapy. In vitro mutagenesis, drug susceptibility assay, and molecular modeling studies were performed. The rtL269I substitution conferred 2- to 7-fold higher replication capacity in the wild-type (WT) or YMDD mutation backbone, regardless of drug treatment. The rtL269I substitution alone did not confer resistance to LMV, ETV, adefovir (ADV), or tenofovir (TDF). However, upon combination with YMDD mutation, the replication capacity under LMV or ETV treatment was enhanced by several folds. Molecular modeling studies suggested that the rtL269I substitution affects template binding, which may eventually lead to the enhanced activity of rtI269-HBV polymerase in both WT virus and YMDD mutant. The clinical relevance of the rtL269I substitution was...Continue Reading
References
Feb 14, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·M MelegariJ R Wands
May 19, 1998·Nature Medicine·T M BlockR A Dwek
Nov 30, 1998·Science·H HuangS C Harrison
Apr 20, 2001·Journal of Virology·K DasE Arnold
Feb 8, 2003·Science·Karl DeresHelga Rübsamen-Waigmann
Feb 28, 2003·The New England Journal of Medicine·Patrick MarcellinUNKNOWN Adefovir Dipivoxil 437 Study Group
Oct 15, 2003·Journal of Virology·William E DelaneyShelly Xiong
Mar 15, 2005·Gastroenterology·Hui-Lin WuPei-Jer Chen
Dec 21, 2005·Journal of Hepatology·Stephen Locarnini, William S Mason
Mar 10, 2006·The New England Journal of Medicine·Ting-Tsung ChangUNKNOWN BEHoLD AI463022 Study Group
Feb 3, 2007·Journal of Virology·David R LangleyDaniel J Tenney
Mar 30, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jay H HoofnagleAnna S F Lok
Apr 6, 2007·Gastroenterology·Marc Ghany, T Jake Liang
Sep 10, 2009·Gastroenterology·Fabien Zoulim, Stephen Locarnini
Feb 19, 2010·Journal of Virology·So Young KwonKyun-Hwan Kim
Feb 20, 2010·PloS One·Ann W WalshDaniel J Tenney
Aug 31, 2010·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Kyun-Hwan KimBaik-Lin Seong
Oct 18, 2011·The Journal of Antimicrobial Chemotherapy·Chih-Lang LinChau-Ting Yeh
Mar 9, 2012·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Dong JiDongping Xu
Mar 1, 2010·Expert Opinion on Drug Discovery·Kyun-Hwan KimBaik-Lin Seong
Aug 16, 2012·Clinical and Molecular Hepatology·UNKNOWN Korean Association for the Study of the Liver
Dec 4, 2012·Acta Pharmacologica Sinica·Jing LiHua-liang Jiang
May 7, 2013·Biochimica Et Biophysica Acta·Gu-Choul ShinKyun-Hwan Kim
Oct 18, 2013·Clinical and Molecular Hepatology·Hyung Joon Yim, Seong Gyu Hwang
Apr 4, 2014·Journal of Virology·Sung Hyun AhnKyun-Hwan Kim
Jun 11, 2014·World Journal of Gastroenterology : WJG·Jeong Han KimKyun-Hwan Kim
Apr 8, 2015·World Journal of Hepatology·Yoshihiko YanoYoshitake Hayashi
Citations
Jul 28, 2017·Viruses·Xizhan XuTong Li
Feb 7, 2018·Hepatology Communications·Norie YamadaTakanobu Kato
Mar 15, 2019·Emerging Microbes & Infections·Yan LiuDongping Xu
Aug 18, 2018·Nature Communications·Doo Hyun KimKyun-Hwan Kim
Aug 14, 2019·Frontiers in Immunology·So-Young LeeBum-Joon Kim
Mar 12, 2020·Virus Evolution·Elin TeppaAlessandra Carbone
Feb 11, 2021·International Journal of Molecular Sciences·Ah Ram LeeKyun-Hwan Kim
Mar 25, 2019·Antiviral Research·Yongmei ZhangHaitao Guo
Apr 20, 2021·Wellcome Open Research·Jolynne MokayaPhilippa C Matthews